Robert Reiter

Robert Reiter is a prominent figure in the field of urology and oncology, serving as the Founder and Chief Medical Officer at ImaginAb, a company focused on developing innovative imaging agents for cancer diagnostics. He is also a Professor of Urology at UCLA, where he plays a significant role in advancing research and clinical practices related to urologic cancers, particularly prostate cancer.

Education and Career

• Medical Background: Dr. Reiter has an extensive background in medicine, holding an MD and an MBA. His academic pursuits have led him to focus on the molecular biology of urologic cancers, translating laboratory discoveries into clinical applications.
• Clinical Practice: He has a busy surgical practice dedicated to prostate cancer and is involved in numerous clinical trials aimed at improving treatment outcomes for patients with urologic malignancies.

Research Interests

Dr. Reiter's research primarily revolves around:

• Discovering novel cell surface and secreted proteins associated with prostate cancer progression.
• Conducting clinical trials to evaluate new therapeutic approaches.

Leadership Roles

In addition to his role at ImaginAb, he serves as:

• Assistant Dean of Bio-entrepreneurship at UCLA.
• Director of the Urologic Oncology and Prostate Cancer Program at UCLA, where he oversees various initiatives aimed at enhancing patient care and advancing research in urologic oncology.

Contributions to the Field

Dr. Reiter is recognized for his contributions to both clinical practice and research in urologic oncology. His work not only impacts patient care but also contributes significantly to the scientific community's understanding of cancer biology.

For further details about his professional background, you can view his LinkedIn profile here .1